Product Information for the Patient
Donepezilo Viatris 5 mg Film-Coated Tablets EFG
Donepezil Hydrochloride
Read this entire product information carefully before starting to take this medicine, as it contains important information for you.
Donepezilo Viatris contains the active substance donepezil hydrochloride, whichbelongs to a group of medicines called cholinesterase inhibitors. Donepezil hydrochloride increases the levels of a substance (acetylcholine) in the brain, involved in memory function, by reducing the rate of breakdown of that substance.
It is used to treat the symptoms of dementia in people diagnosed with mild to moderately severe Alzheimer's disease.
The symptoms of the disease include an increase in memory loss, increase in confusion, and changes in behavior. As a result, Alzheimer's patients have more difficulty performing their normal daily activities.
Do not take Donepezilo Viatris
Warnings and precautions
Consult your doctor or pharmacist before starting to take donepezilo if you suffer or have ever suffered from any of the following conditions:
Children and adolescents
Children and adolescents under 18 years old should not take this medication.
Other medications and Donepezilo Viatris
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription. Especially, inform your doctor or pharmacist if you are taking some of the following:
If you are to undergo surgery, including dental surgery, in which you will need to be administered anesthesia, inform your doctor, dentist, hospital staff, or anesthesiologist that you are taking this medication.
Taking Donepezilo Viatris with food, alcohol
You should avoid drinking alcohol while taking this medication, as it may reduce the effect of donepezilo.
Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, or intend to become pregnant, do not take this medication before speaking with your doctor to request advice..Donepezilo should not be used during pregnancy except in clearly necessary cases.
Donepezilo should not be used during breastfeeding.
Driving and operating machinery
Do not drive or operate tools or machines if you feel dizzy, drowsy, and muscle cramps while taking this medication. Additionally, Alzheimer's disease may affect your ability to drive or operate machines, so you should not perform these activities unless your doctor tells you that you can.
Donepezilo Viatris contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Tell your doctor the name of your caregiver. Your caregiver will help you take the medication as prescribed.
Adults
The recommended starting dose is 5 mg of donepezil once a day for at least one month. Your doctor may increase the dose to 10 mg of donepezil per day. The maximum recommended dose is 10 mg per day. If you experience an increase in adverse effects while taking the 10 mg per day dose, consult your doctor or pharmacist.
Use in patients with liver and kidney disease
Your doctor may need to adjust the dose in adults with some liver disease, from mild to moderate. No dose adjustment is required if you have kidney problems.
Administration form:
Take donepezil orally with a glass of water at night before going to bed.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take donepezil in the morning.
Your doctor will advise you on how long to continue taking the tablets. You will need to visit your doctor regularly to review your treatment and evaluate your symptoms. You can take this medication with or without food.
If you take more Donepezilo Viatristhan you should
Do not take more than one tablet a day. Contact your doctor or the nearest hospital emergency service immediately if you take more tablets than you should. Bring the box and the remaining tablets to the hospital so that the doctor knows what has been taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20. Bring the packaging and the remaining tablets with you.
If you take more donepezil than you should, symptoms such as a feeling of discomfort (nausea), vomiting, salivation, sweating, slow heart rate (bradycardia), low blood pressure (dizziness or vertigo when standing), respiratory problems, loss of consciousness, seizures (attacks). An increase in muscle weakness may also occur, which could be life-threatening when respiratory muscles are involved.
If you forget to take DonepeziloViatris
If you forget to take a dose, take only one dose the next day at the usual time. Do not take a double dose to compensate for the missed doses.
If you forget to take the medication for more than a week, consult your doctor before resuming the medication.
If you interrupt treatment with DonepeziloViatris
When treatment is interrupted, the beneficial effects of donepezil will decrease gradually.
Do not stop taking the medication without consulting your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Inform your doctor or go to the nearest hospital emergency service immediately if you experience any of the following side effects:
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data)
Other side effects include:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from available data)
Torticollis (a condition that involves involuntary muscle contraction with abnormal flexion of the body and head to one side).
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Donepezilo Viatris
Coating of the tablet: hypromellose, titanium dioxide (E-171) and macrogol 400.
Appearance of the product and packaging size
Your medicine is presented in the form offilm-coated tablets, round, white, marked with “DL” over a “5”on one side and “G” on the reverse.
It is available in packaging sizes of:7, 10, 28, 30, 56, 60, 84, 98, 100film-coated tablets,calendar pack of 28 and 98 and blister pack of 50 x 1.
It is available in bottles containing 100 and 250 film-coated tablets.
Only some packaging sizes may be marketed.
Marketing authorization holder and responsible for manufacturing
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible for manufacturing
Mylan Hungary Kft.
Mylan utca 1
H-2900 Komárom
Hungary
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
SpainDonepezilo Viatris 5 mg film-coated tablets EFG
FranceDONEPEZIL MYLAN 5 mg, coated tablet
GreeceDONEPEZIL/MYLAN
IrelandAripil 5 mg Film-coated Tablets
ItalyDONEPEZIL MYLAN GENERICS
PolandPamigen
PortugalDonepezilo Mylan
United Kingdom (NI)Donepezil Hydrochloride 5 mg Film-coated Tablets
Czech RepublicDonepezil Mylan 5 mg
SwedenDonepezil Mylan
Last review date of this leaflet: April 2023
The detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) https://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.